| # | Drug | Count |
|---|---|---|
| 0 | DASATINIB | 31 |
| 1 | ADALIMUMAB | 26 |
| 2 | INFLIXIMAB | 19 |
| 3 | METHOTREXATE | 19 |
| 4 | METHOTREXATE SODIUM | 19 |
| 5 | LAMOTRIGINE | 14 |
| 6 | ETANERCEPT | 13 |
| 7 | RITUXIMAB | 13 |
| 8 | TACROLIMUS | 13 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND CHLOROXYLENOL | 1 | 0.0222 |
| 1 | HOMOSALATE, OCTISALATE, AVOBENZONE, AND DIMETHICONE | 1 | 0.0217 |
| 2 | AURANOFIN | 2 | 0.0098 |
| 3 | DASATINIB | 31 | 0.0033 |
| 4 | PENICILLAMINE | 2 | 0.0022 |
| 5 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 6 | MECASERMIN | 1 | 0.0012 |
| 7 | ALOSETRON HYDROCHLORIDE | 1 | 0.0012 |
| 8 | CHLORPROMAZINE HYDROCHLORIDE | 1 | 0.0010 |
| 9 | HUMAN RHO(D) IMMUNE GLOBULIN | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 1 | Corticosteroid [EPC] | 26 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 3 | Mood Stabilizer [EPC] | 22 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 5 | Anti-epileptic Agent [EPC] | 18 |
| 6 | Benzodiazepine [EPC] | 15 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 13 |
| 8 | Alkylating Drug [EPC] | 11 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Actinomycin [EPC] | 1 | 0.0005 |
| 3 | Human Immunoglobulin G [EPC] | 9 | 0.0004 |
| 4 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 7 | Interleukin-17A Antagonist [EPC] | 9 | 0.0002 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 9 | Somatostatin Analog [EPC] | 1 | 0.0001 |